Works matching DE "CYTOCHROME P-450 CYP3A"

Results: 744

Polymorphisms in CYP3A5, CYP3A4 , and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1569353

By:

Costa-Junior, Luiz Carlos da;
Freitas-Alves, Daniely Regina;
Leão, Amanda Melo Leite;
Monteiro, Hayra de Andrade Vieira;
Tavares, Rita de Cássia Barbosa da Silva;
Moreira, Maria Claudia Rodrigues;
Visacri, Marília Berlofa;
Fernandez, Teresa de Souza;
Santos, Paulo Caleb Júnior de Lima

Publication type:

Article

Does One Size Fits All?

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1099, doi. 10.1007/s10557-024-07625-6

By:

Roldan, Vanessa;
Badimon, Juan Jose

Publication type:

Article

Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1315, doi. 10.1007/s10557-023-07495-4

By:

Li, Xiaoye;
Gu, Zhichun;
Wang, Zi;
Xu, Qing;
Ma, Chunlai;
Lv, Qianzhou

Publication type:

Article

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 747, doi. 10.1007/s10557-023-07443-2

By:

Lenard, Alexander;
Hermann, Simon A.;
Stoll, Felicitas;
Burhenne, Juergen;
Foerster, Kathrin I.;
Mikus, Gerd;
Meid, Andreas D.;
Haefeli, Walter E.;
Blank, Antje

Publication type:

Article

Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 459, doi. 10.1007/s10557-022-07405-0

By:

Hou, Qingtao;
Chen, Yuqin;
Zhang, Yingxiao;
Pang, Caishuang

Publication type:

Article

In Silico Studies and In Vitro Microsomal Metabolism of Potent Metap2 Inhibitor And In Vivo Tumor Suppressor for Prostate Cancer: A Thioether-Triazole Hybrid.

Published in:

Acibadem Saglik Bilimleri Dergisi, 2023, v. 14, n. 1, p. 10, doi. 10.31067/acusaglik.1210129

By:

Coşkun, Göknil Pelin;
Birgül, Kaan;
Evren, Asaf Evrim;
Küçükgüzel, Ş. Güniz;
Ülgen, Mert

Publication type:

Article

Gene expression of MTATP6 and cytochrome P450 in MCF-7 and MDA-MB -231 breast cancer cell lines with juglone and curcumin supplemented.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2025, v. 44, n. 9, p. 750, doi. 10.1080/15257770.2024.2418907

By:

Korucu, Emine Nedime;
Aydemir, Saliha;
Menevse, Esma;
Erkoc Kaya, Dudu;
Azzawri, Ali Ahmed

Publication type:

Article

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.

Published in:

NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00692-w

By:

Schlam, Ilana;
Smith, D. Max;
Peer, Cody;
Sissung, Tristan;
Schmidt, Keith T.;
Tan, Ming;
Chitalia, Ami;
Bishopric, Nanette H.;
Steinberg, Seth;
Choo-Wosoba, Hyoyoung;
Napoli, Giulia;
Gallagher, Christopher;
Ashai, Nadia;
Whitaker, Kristen;
Mainor, Candace;
Tiwari, Shruti;
Swanson, Nicole;
Malloy, Stacy;
Isaacs, Claudine;
Figg, William Douglas

Publication type:

Article

Cariprazine: A third-generation antipsychotic with a twist.

Published in:

Medicine Today, 2022, v. 23, n. 6, p. 55

By:

HOPE, JUDITH D.;
KEKS, NICHOLAS A.

Publication type:

Article

Colchicine may decrease cardiovascular events in patients with coronary artery disease.

Published in:

2022

By:

Griffin, Leslie;
Groce, Julia;
Conway, Sara

Publication type:

journal article

Exploration of pharmacokinetic differences between East Asians and Caucasians: insights from pharmacokinetic studies in healthy subjects.

Published in:

Translational & Clinical Pharmacology, 2024, v. 32, n. 3, p. 127, doi. 10.12793/tcp.2024.32.e15

By:

Yoonjin Kim;
Sungyeun Bae;
Woo Kyung Chung;
Jihoon Kwon;
Ildae Song;
SeungHwan Lee

Publication type:

Article

Development and validation of a method for the simultaneous quantification of endogenous steroids metabolized by CYP3A.

Published in:

Translational & Clinical Pharmacology, 2020, v. 28, n. 2, p. 73, doi. 10.12793/tcp.2020.28.e10

By:

Yujin Lee;
Woori Chae;
Seonghae Yoon;
Jae-Yong Chung;
Joo-Youn Cho

Publication type:

Article

Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.

Published in:

2022

By:

Cheng, Fang;
Li, Qiang;
Cui, Zheng;
Wang, Zhendi;
Zeng, Fang;
Zhang, Yu

Publication type:

journal article

Development and Verification of a Physiologically Based Pharmacokinetic Model of Furmonertinib and Its Main Metabolite for Drug–Drug Interaction Predictions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 7, p. 1273, doi. 10.1002/psp4.70052

By:

Wu, Yali;
Loer, Helena Leonie Hanae;
Zhang, Yifan;
Zhong, Dafang;
Jiang, Yong;
Hu, Jie;
Fuhr, Uwe;
Lehr, Thorsten;
Diao, Xingxing

Publication type:

Article

Elucidating Contributions of Drug Transporters/Enzyme to Nonlinear Pharmacokinetics of Grazoprevir by PBPK Modeling With a Cluster Gauss–Newton Method.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 4, p. 770, doi. 10.1002/psp4.13314

By:

Yoshikado, Takashi;
Aoki, Yasunori;
Nakamura, Ryo;
Shida, Saeko;
Sugiyama, Yuichi;
Chiba, Koji

Publication type:

Article

Population pharmacokinetic and pharmacodynamic model of evogliptin: Severe uremia increases the bioavailability of evogliptin.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 2, p. 246, doi. 10.1002/psp4.13263

By:

Kim, Byungwook;
Kim, Jung Eun;
Lee, Soyoung;
Oh, Jaeseong;
Cho, Joo‐Youn;
Jang, In‐Jin;
Lee, SeungHwan;
Chung, Jae‐Yong;
Yoon, Seonghae

Publication type:

Article

PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 130, doi. 10.1002/psp4.13249

By:

Henriot, Justine;
Dallmann, André;
Dupuis, François;
Perrier, Jérémy;
Frechen, Sebastian

Publication type:

Article

Physiologically based pharmacokinetic modeling of drug–drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 11, p. 1967, doi. 10.1002/psp4.13268

By:

Atoyebi, Shakir;
Montanha, Maiara Camotti;
Nakijoba, Ritah;
Orrell, Catherine;
Mugerwa, Henry;
Siccardi, Marco;
Denti, Paolo;
Waitt, Catriona

Publication type:

Article

Pharmacometrics in obstetrics and maternal–fetal medicine research: Bridging gaps in maternal and fetal pharmacology.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 11, p. 1835, doi. 10.1002/psp4.13267

By:

Eke, Ahizechukwu C.;
Adams, Emily;
Eleje, George U.;
Ezebialu, Ifeanyichukwu U.;
Aliyu, Muktar H.

Publication type:

Article

Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1570, doi. 10.1002/psp4.13192

By:

Johnson, Trevor N.;
Batchelor, Hannah K.;
Goelen, Jan;
Horniblow, Richard D.;
Dinh, Jean

Publication type:

Article

Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug–drug interactions explored within a PBPK framework.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1513, doi. 10.1002/psp4.13188

By:

Hartauer, Mattie;
Murphy, William A.;
Brouwer, Kim L. R.;
Southall, Roz;
Neuhoff, Sibylle

Publication type:

Article

Impact of obesity and roux‐en‐Y gastric bypass on the pharmacokinetics of (R)‐ and (S)‐omeprazole and intragastric pH.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1528, doi. 10.1002/psp4.13189

By:

Pippa, Leandro F.;
Vozmediano, Valvanera;
Mitrov‐Winkelmolen, Lieke;
Touw, Daan;
Soliman, Amira;
Cristofoletti, Rodrigo;
Salgado Junior, Wilson;
de Moraes, Natalia Valadares

Publication type:

Article

Physiologically‐based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co‐administered with ritonavir.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1503, doi. 10.1002/psp4.13184

By:

Sun, Zexu;
Zhao, Nan;
Xie, Ran;
Jia, Bo;
Xu, Junyu;
Luo, Lin;
Zhuang, Yulei;
Peng, Yuyu;
Liu, Xinchang;
Zhang, Yingjun;
Zhao, Xia;
Liu, Zhaoqian;
Cui, Yimin

Publication type:

Article

Understanding CYP3A4 and P‐gp mediated drug–drug interactions through PBPK modeling – Case example of pralsetinib.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 660, doi. 10.1002/psp4.13114

By:

Bowman, Christine;
Dolton, Michael;
Ma, Fang;
Cheeti, Sravanthi;
Kuruvilla, Denison;
Sane, Rucha;
Kassir, Nastya;
Chen, Yuan

Publication type:

Article

Physiologically‐based pharmacokinetic modeling of the drug–drug interaction between ivacaftor and lefamulin in cystic fibrosis patients.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 589, doi. 10.1002/psp4.13103

By:

Amiel, Magali;
Ke, Alice;
Gelone, Steven P.;
Jones, Hannah M.;
Wicha, Wolfgang

Publication type:

Article

Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 624, doi. 10.1002/psp4.13106

By:

Hanley, Michael J.;
Yeo, Karen Rowland;
Tugnait, Meera;
Iwasaki, Shinji;
Narasimhan, Narayana;
Zhang, Pingkuan;
Venkatakrishnan, Karthik;
Gupta, Neeraj

Publication type:

Article

Physiologically‐based pharmacokinetic model of sparsentan to evaluate drug–drug interaction potential.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 2, p. 317, doi. 10.1002/psp4.13086

By:

Patel, Nikunjkumar K.;
Chen, Kuan‐Fu;
Chen, Shang‐Chiung;
Liu, Kai

Publication type:

Article

Assessment of CYP3A‐mediated drug interaction via cytokine (IL‐6) elevation for mosunetuzumab using physiologically‐based pharmacokinetic modeling.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 2, p. 234, doi. 10.1002/psp4.13073

By:

Chen, Yuan;
Ma, Fang;
Jones, Nicholas;
Deng, Rong;
Li, Chunze;
Li, Chi‐Chung

Publication type:

Article

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 8, p. 1143, doi. 10.1002/psp4.12981

By:

Feick, Denise;
Rüdesheim, Simeon;
Marok, Fatima Zahra;
Selzer, Dominik;
Loer, Helena Leonie Hanae;
Teutonico, Donato;
Frechen, Sebastian;
van der Lee, Maaike;
Moes, Dirk Jan A. R.;
Swen, Jesse J.;
Schwab, Matthias;
Lehr, Thorsten

Publication type:

Article

Population PK/PD model of tacrolimus for exploring the relationship between accumulated exposure and quantitative scores in myasthenia gravis patients.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 7, p. 963, doi. 10.1002/psp4.12966

By:

Chen, Di;
Yao, Qingyu;
Chen, Wenjun;
Yin, Jian;
Hou, Shifang;
Tian, Xiaoxin;
Zhao, Ming;
Zhang, Hua;
Yang, Liping;
Zhou, Tianyan;
Jin, Pengfei

Publication type:

Article

Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drug.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 6, p. 808, doi. 10.1002/psp4.12954

By:

Salem, Farzaneh;
Nimavardi, Ali;
Mudunuru, Jennypher;
Tompson, Debra;
Bloomer, Jackie;
Turner, David B.;
Taskar, Kunal S.

Publication type:

Article

Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 5, p. 724, doi. 10.1002/psp4.12946

By:

Loer, Helena Leonie Hanae;
Feick, Denise;
Rüdesheim, Simeon;
Selzer, Dominik;
Schwab, Matthias;
Teutonico, Donato;
Frechen, Sebastian;
van der Lee, Maaike;
Moes, Dirk Jan A. R.;
Swen, Jesse J.;
Lehr, Thorsten

Publication type:

Article

Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 532, doi. 10.1002/psp4.12939

By:

Mulford, Darcy J.;
Ramsden, Diane;
Zhang, Liming;
Michon, Ingrid;
Leifke, Eckhard;
Smith, Neila;
Jones, Hannah M.;
Scarpignato, Carmelo

Publication type:

Article

Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 2, p. 261, doi. 10.1002/psp4.12901

By:

Ladumor, Mayur K.;
Storelli, Flavia;
Liang, Xiaomin;
Lai, Yurong;
Enogieru, Osatohanmwen J.;
Chothe, Paresh P.;
Evers, Raymond;
Unadkat, Jashvant D.

Publication type:

Article

Physiologically‐based pharmacokinetic modeling for primary metabolites of CYP3A and P‐glycoprotein inhibitors in drug–drug interactions: Should we assume the free drug hypothesis?

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 1, p. 8, doi. 10.1002/psp4.12879

By:

Yamazaki, Shinji;
Evers, Raymond;
De Zwart, Loeckie

Publication type:

Article

PBPK perspective on alternative CYP3A4 inducers for rifampin.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1543, doi. 10.1002/psp4.12864

By:

Chen, Kuan‐Fu;
Jones, Hannah M.

Publication type:

Article

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 11, p. 1430, doi. 10.1002/psp4.12844

By:

Ngo, Lien Thi;
Yang, Sung‐yoon;
Shin, Sooyoung;
Cao, Duc Tuan;
Van Nguyen, Hung;
Jung, Sangkeun;
Lee, Jae‐Young;
Lee, Jong‐Hwa;
Yun, Hwi‐yeol;
Chae, Jung‐woo

Publication type:

Article

Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 9, p. 1194, doi. 10.1002/psp4.12837

By:

Prieto Garcia, Luna;
Lundahl, Anna;
Ahlström, Christine;
Vildhede, Anna;
Lennernäs, Hans;
Sjögren, Erik

Publication type:

Article

Evaluation of drug–drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 894, doi. 10.1002/psp4.12805

By:

Ji, Tao;
Chen, Xuejun;
Yeleswaram, Swamy

Publication type:

Article

Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 2, p. 199, doi. 10.1002/psp4.12746

By:

Wendl, Thomas;
Frechen, Sebastian;
Gerisch, Michael;
Heinig, Roland;
Eissing, Thomas

Publication type:

Article

Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 1, p. 30, doi. 10.1002/psp4.12730

By:

Lenoir, Camille;
Niederer, Amine;
Rollason, Victoria;
Desmeules, Jules Alexandre;
Daali, Youssef;
Samer, Caroline Flora

Publication type:

Article

Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P‐glycoprotein–cytochrome P450 3A4 dual substrates.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 12, p. 1485, doi. 10.1002/psp4.12717

By:

Pan, Xian;
Yamazaki, Shinji;
Neuhoff, Sibylle;
Zhang, Mian;
Pilla Reddy, Venkatesh

Publication type:

Article

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 9, p. 1107, doi. 10.1002/psp4.12682

By:

De Zwart, Loeckie;
Snoeys, Jan;
Jacobs, Frank;
Li, Lilian Y.;
Poggesi, Italo;
Verboven, Peter;
Goris, Ivo;
Scheers, Ellen;
Wynant, Inneke;
Monshouwer, Mario;
Mamidi, Rao N. V. S.

Publication type:

Article

Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 5, p. 455, doi. 10.1002/psp4.12606

By:

Ueno, Takashi;
Miyajima, Yukiko;
Landry, Ishani;
Lalovic, Bojan;
Schuck, Edgar

Publication type:

Article

A systematic review of the drug-drug interaction between Statins and Quinolones.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-024-00760-8

By:

Zhou, Jifang;
Yu, Lixia;
Xu, Huimin

Publication type:

Article

Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-023-00726-2

By:

Jia, Guangwei;
Ren, Congcong;
Wang, Hongyan;
Fan, Caixia

Publication type:

Article

Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB -Knockout Human Hepatoma Cells.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020140

By:

Tabata, Yuki;
Shidoji, Yoshihiro

Publication type:

Article

Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV.

Published in:

Infectious Diseases & Therapy, 2025, v. 14, n. 6, p. 1313, doi. 10.1007/s40121-025-01154-x

By:

Thakkar, Nilay;
Griesel, Rulan;
Pierce, Amy;
Bainbridge, Veronica;
Shepherd, Bronagh;
Angelis, Konstantinos;
Tomlinson, Andrew;
Gandhi, Yash;
Brimhall, Darin;
Anderson, Daijha;
Andrews, Susan;
Acuipil, Carolina;
McCoig, Cynthia;
Baker, Mark;
Benn, Paul

Publication type:

Article

Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIV.

Published in:

Infectious Diseases & Therapy, 2025, v. 14, n. 5, p. 1011, doi. 10.1007/s40121-025-01129-y

By:

Thakkar, Nilay;
Griesel, Rulan;
Pierce, Amy;
Bainbridge, Veronica;
Shepherd, Bronagh;
Angelis, Konstantinos;
Tomlinson, Andrew;
Gandhi, Yash;
Brimhall, Darin;
Spears, Brian;
Anderson, Daijha;
Pinnick, Emma;
Acuipil, Carolina;
McCoig, Cynthia;
Baker, Mark;
Benn, Paul

Publication type:

Article

Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative Review.

Published in:

Infectious Diseases & Therapy, 2024, v. 13, n. 5, p. 1005, doi. 10.1007/s40121-024-00959-6

By:

Quercia, Romina;
Di Perri, Giovanni;
Pein, Carolina;
Bodie, Jennifer;
Singh, Ravi Shankar P.;
Hendrick, Victoria;
Boffito, Marta

Publication type:

Article